Related by context. Frequent words. (Click for all words.) 61 commercializing therapeutic 60 sodium Injection 60 Onalta 60 pseudobulbar affect PBA 59 Panzem R 59 oral calcitonin 59 FDA Accepts 58 Pivotal Phase III 58 Palatin Technologies Inc. 58 Patient Enrollment 57 ATryn ® 57 HCV protease inhibitor 57 ZALBIN 57 non alcoholic steatohepatitis 57 Veronate 57 opioid induced constipation 56 methylnaltrexone 56 diabetic peripheral neuropathic pain 56 Zelrix 56 Omigard 56 Pivotal Phase 56 ALN TTR# 56 BEMA Buprenorphine 56 Phase III Clinical Trial 55 humanized anti 55 Hepatitis C HCV 55 MEK inhibitor 55 Staccato loxapine 55 diabetic neuropathic pain 55 diabetic macular edema DME 55 Oscient Pharmaceuticals Corporation 55 elotuzumab 55 Phase IIa clinical trials 55 ONSOLIS 55 SANCTURA R 55 OLEPTRO TM 55 epothilone 55 Eligard R 55 Celsion Corporation 54 postherpetic neuralgia PHN 54 KNS # 54 alvimopan 54 Extended Release 54 Nasdaq VRTX 54 ATryn R 54 ONTAK 54 autoimmune indications 54 tetrabenazine 54 humanized monoclonal antibody 54 Opana ER 54 Extended Release Tablets 54 painful diabetic neuropathy 53 anticancer compound 53 ImmuneRegen BioSciences Inc. 53 AeroLEF 53 KRYSTEXXA 53 BCX# 53 Pirfenidone 53 Pharmion Corporation 53 SILENOR TM 53 Phase III Trial 53 Onsolis 53 Nexavar ® 53 sNDA 53 BEMA Fentanyl 53 Orphan Drug designation 52 Strativa 52 IND enabling 52 GEM #S 52 Pivotal Trial 52 IND submission 52 QNEXA 52 Exalgo 52 commercialization milestones 52 Loramyc ® 52 Gabapentin GR 52 ecallantide 52 registrational 52 Phase 2b clinical 52 investigational drug 52 Cotara R 52 Bone Graft 52 Phase III clinical trials 52 Fast Track designation 52 Cinryze TM 52 Hybridon 52 TOCOSOL Paclitaxel 52 topical gel 52 teduglutide 51 Chemokine Therapeutics 51 Fast Track Designation 51 Oral Solution 51 Biologics License Application BLA 51 PREOS 51 Ventavis 51 Relistor 51 Ofatumumab 51 Act PDUFA date 51 Solzira 51 phase IIb 51 PRISTIQ